We found that samples representing those two clusters did not differ with any of the following features: tumor stage, tumor grade, response to chemotherapy, residual tumor size, germline breast cancer (BRCA)1 mutation, somatic p53 mutation, or p53 protein accumulation. This evidence concerns the gene BRCA1 and medical procedure.